+
Site Tour

Debate: Factor XI inhibitors are close J. Camm

13th Annual International Left Atrial Appendage Occlusion (LAAO) Summit - Debate: Factor XI inhibitors are not far away by John Camm

LEARN MORE:

LAAO Summit 2024

Related Videos

LAAO Summit - LAAO in a patient at risk of DRT

LAAO Summit - Pre-procedural imaging

LAAO Summit - Imaging debate: ICE

LAAO Summit - Mastering leaks

ESOC 2023: LAAO case

LAAO Summit - Imaging debate: Mini TEE

LAAO Summit 2023: Anatomy & imaging – Panel

LAAO Summit 2023: LAAO therapies

LAAO Summit 2023: Complications

LAAO Summit 2023: Successful implant

LAAO Summit - LAA anatomy focusing

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

LAAO Summit - Debate: Factor XI inhibitors

LAAO Summit 2022: Live case: Denmark

Review the Trends | Tricuspid focus

LAAO Summit - LAA anatomy focusing

CONNEXT


HUB
RELATED RESOURCES

Data Summary PFO closure in patients > 60 Years

PCR LV 2021: Navitor™ Live-in-a-box

Amplatzer™ Amulet™ LAA Occluder

LAAO Patient Guide

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline